Skip to main content
. 2023 May 18;7(4):543–552. doi: 10.1002/ags3.12689

FIGURE 5.

FIGURE 5

Pathway‐centric risk classification for patients with colorectal liver metastases. (A) Grades assigned according to APC, TP53, RAS/BRAF, and SMAD4 mutation status. (B) Overall survival by grade. (C) Overall survival by grade in a validation cohort from Memorial Sloan Kettering Cancer Center. (Adapted from Kawaguchi et al 33 with permission.)